Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. The company is headquartered in Wuxi, Jiangsu and currently employs 31 full-time employees. The company went IPO on 2024-12-27. The firm mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The firm's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The firm mainly conducts its business in domestic market.
Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Hasılat
67
67
53
0
0
0
Hasılat Artışı (YoY)
26%
26%
--
--
--
--
Satınalma Maliyeti
0
0
--
--
--
--
Brüt Kâr
17
67
--
--
--
--
Satış, Genel ve İdari
119
119
77
50
47
46
Araştırma ve Geliştirme
251
251
169
115
92
84
İşletme Giderleri
371
371
247
165
139
131
Diğer Finansman Gelirleri (Giderleri)
--
--
0
0
0
--
Kâr Öncesi Gelir
-278
-278
-171
-152
-135
-130
Kira Vergisi Gideri
0
0
2
--
--
--
Net Kâr
-278
-278
-173
-152
-135
-130
Net Income Growth
Kâr Artışı
61%
61%
14%
13%
4%
46%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
88.05
87.67
86.16
73.22
66.99
66.35
Hisse Değişimi (Yıllık Üst Üste)
1%
2%
18%
9%
1%
25%
EPS (Diluted)
-3.17
-3.17
-2.01
-2.08
-2.03
-1.97
EPS Artışı
60%
56.99%
-3%
3%
3%
17%
Öz sermaye akışı
-70
-70
133
-124
-110
-105
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
25.37%
100%
--
--
--
--
Faaliyet Kâr Marjı
-452.23%
-452.23%
-364.15%
0%
0%
0%
Kâr Marjı
-414.92%
-414.92%
-326.41%
0%
0%
0%
Özsermaye Karlılık Oranı
-104.47%
-104.47%
250.94%
0%
0%
0%
EBITDA
-302
-302
-193
-165
-139
-131
EBITDA Marjinali
-450.74%
-450.74%
-364.15%
0%
0%
0%
D&A EBITDA için
1
1
0
0
0
0
Faaliyet Kârı
-303
-303
-193
-165
-139
-131
Faaliyet Kâr Marjı
-452.23%
-452.23%
-364.15%
0%
0%
0%
Verilen Vergi Oranı
0%
0%
-1.16%
--
--
--
Follow-Up Questions
Quels sont les états financiers clés de Park Ha Biological Technology Co Ltd ?
Selon le dernier état financier (Form-10K), Kura Oncology Inc a un total d'actifs de $738, un bénéfice net kayıp de $-278
Quels sont les ratios financiers clés pour PHH ?
Le ratio de liquidité de Kura Oncology Inc est 1.3, la marge nette est -414.92, les ventes par action sont de $0.76.
Comment les revenus de Park Ha Biological Technology Co Ltd sont-ils répartis par segment ou géographie ?
Kura Oncology Inc en büyük gelir kaynağı Precision Medicines olup, en son kar bildiriminde geliri 53,883,000 dir. Coğrafi olarak, United States , Kura Oncology Inc için ana pazar olup, geliri 53,883,000 dir.
Park Ha Biological Technology Co Ltd est-elle rentable ?
hayır, selon les derniers états financiers, Kura Oncology Inc a un bénéfice net kayıp de $-278
Park Ha Biological Technology Co Ltd a-t-elle des passifs ?
evet, Kura Oncology Inc a un passif de 564
Combien d'actions en circulation Park Ha Biological Technology Co Ltd a-t-elle ?
Kura Oncology Inc a un total d'actions en circulation de 87.85